Please login to the form below

Not currently logged in
Email:
Password:

oncolytic viruses

This page shows the latest oncolytic viruses news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolts on another immuno-oncology company

Boehringer bolts on another immuno-oncology company

The company currently has clinical-phase projects ranging across checkpoint inhibitors, oncolytic viruses, cancer vaccines and T-cell engagers, with around half of its early-to-mid-stage pipeline emerging from ... 2006. Other oncolytic virus candidates

Latest news

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    cell-based therapies and oncolytic viruses that attack malignant cells directly, and cancer vaccines that try to kickstart an intrinsic immune reaction to the tumour. ... Oncolytic viruses. An oncolytic virus is a virus that preferentially infects and

  • Gene therapy Gene therapy

    From a payload perspective, these include new technologies such as siRNA, Sleeping Beauty transposases, CRISPR-Cas9 gene editing, ARCUS gene editing, nucleic acid vaccines, oncolytic viruses and chemically modified mRNA. ... In contrast, viruses still

  • Deal Watch December 2016 Deal Watch December 2016

    995+. PsiOxus Therapeutics (UK). BMS (US). Licence. NG-348: preclinical “armed” oncolytic virus targeting tumour cells. ... technology in the development of immunomodulatory oncolytic viruses.

  • The Maverick: giving medicines away free The Maverick: giving medicines away free

    His fundamental idea is to create synthetic viruses that can invade cancer cells, destroy them, and then multiply into more viruses to kill the remaining cancerous cells. ... This forms part of a new research area known as oncolytic virology that uses

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Turnstone Biologics bolsters leadership team Turnstone Biologics bolsters leadership team

    Oncolytic viruses and cancer vaccines have the potential to benefits a wide range of patients living with cancer, and the company’s proprietary viral platform technology is at the forefront of ... we advance clinical development of our next-generation

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics